DIAGNOS (DGNOF) News Today $0.21 -0.01 (-2.98%) As of 01:54 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period DIAGNOS is filing for the Saudi FDA Authorization of Its CARA SYSTEM, an AI Assisted Medical DeviceMarch 12, 2025 | globenewswire.comDIAGNOS Announces Amendment to Convertible DebenturesFebruary 28, 2025 | globenewswire.comDIAGNOS to File for FDA Pre-Market Authorization of Its AI-Powered CARA SYSTEM and Engages Ora as Regulatory SpecialistFebruary 25, 2025 | globenewswire.comCorrection - Diagnos Announces Closing of Private PlacementFebruary 14, 2025 | globenewswire.comDIAGNOS Closes $2 Million Private Placement to Boost AI Screening ServicesFebruary 5, 2025 | tipranks.comDIAGNOS Announces Closing of Private PlacementFebruary 5, 2025 | globenewswire.comDIAGNOS Announces Financial Contribution of $400,000 from the Government of CanadaJanuary 30, 2025 | globenewswire.comDIAGNOS to Present at The Microcap Conference 2025January 28, 2025 | globenewswire.comDIAGNOS Announces the Engagement of PromoterJanuary 13, 2025 | globenewswire.comOpen Thread: November 8, 2024November 8, 2024 | msn.comNorth Dakota woman shares her story about living with undiagnosed PCOS for yearsNovember 6, 2024 | msn.comNGMDF NuGen Medical Devices Inc.October 31, 2024 | seekingalpha.comDIAGNOS Announces Closing of Private PlacementOctober 25, 2024 | globenewswire.comDIAGNOS Announces the Engagement of Market Maker ConsultantOctober 17, 2024 | globenewswire.comTREIF Treatment.com AI Inc.October 16, 2024 | seekingalpha.comDIAGNOS Announces Grant of Stock OptionsOctober 3, 2024 | globenewswire.comDIAGNOS Announces Voting Results of Meeting of ShareholdersSeptember 26, 2024 | globenewswire.comDIAGNOS Announces Variation in One Insider OwnershipSeptember 23, 2024 | globenewswire.comDIAGNOS Announces Closing of Private PlacementSeptember 20, 2024 | globenewswire.comDIAGNOS Announces Date of Annual General and Special Meeting of ShareholdersAugust 22, 2024 | globenewswire.comDIAGNOS Successfully Completes ISO 13485 / MDSAP Audit and receives its certification to move forward with FDA and Health CanadaAugust 20, 2024 | globenewswire.comDIAGNOS Announces Closing of Second and Final Tranche of Private PlacementJune 5, 2024 | globenewswire.comDIAGNOS celebrates the launch of Labtician's new screening service for diabetic retinopathy in Ontario and renews its distribution agreementMay 21, 2024 | globenewswire.comDIAGNOS Announces Closing of First Tranche of Private PlacementMay 9, 2024 | globenewswire.comDIAGNOS to Present Cutting-Edge AI Solutions for Retinal Health at ARVO 2024May 6, 2024 | globenewswire.comDIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certificationApril 16, 2024 | globenewswire.comDIAGNOS Inc. to Present at the AI & Technology Hybrid Investor Conference April 11thApril 9, 2024 | globenewswire.comDIAGNOS Announces Grant of Stock OptionsApril 3, 2024 | globenewswire.comDIAGNOS Welcomes Dr. Philippe Couillard to its Board of DirectorsApril 2, 2024 | globenewswire.comDIAGNOS Announces Closing of Second and Final Tranche of Private PlacementMarch 22, 2024 | globenewswire.comDIAGNOS Announces Grant of Stock OptionsMarch 4, 2024 | globenewswire.comDIAGNOS Welcomes Mr. Michael Braeuel to its Board of DirectorsFebruary 29, 2024 | globenewswire.comDIAGNOS Announces Closing of First Tranche of Private PlacementFebruary 27, 2024 | globenewswire.comDiagnos Announces Variation in One Insider Ownership of Common SharesFebruary 23, 2024 | globenewswire.comDIAGNOS recognized as a Top TSX Venture Exchange CompanyFebruary 21, 2024 | globenewswire.comBest of 2023December 8, 2023 | nytimes.com Remove Ads Get DIAGNOS News Delivered to You Automatically Sign up to receive the latest news and ratings for DGNOF and its competitors with MarketBeat's FREE daily newsletter. Email Address DGNOF Media Mentions By Week DGNOF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DGNOF News Sentiment▼0.000.83▲Average Business Services News Sentiment DGNOF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DGNOF Articles This Week▼10▲DGNOF Articles Average Week Remove Ads Get DIAGNOS News Delivered to You Automatically Sign up to receive the latest news and ratings for DGNOF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Surge Battery Metals News Orosur Mining News Nicox News Blackstone Minerals News Victory Square Technologies News FuelPositive News Poxel News Fobi AI News Nextech3D.AI News Else Nutrition News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:DGNOF) was last updated on 3/17/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DIAGNOS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DIAGNOS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.